Evidence map›Paper›PMID 33746610›Full record

ReviewMediators of inflammation2021

Unraveling the Molecular Nexus between GPCRs, ERS, and EMT.

Niti Kumari, Somrudee Reabroi, Brian J North

Open access · goldAbstract readReview
In one paragraph

Review in Mediators of inflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Pro-inflammatory cytokines disruptFrontiers in endocrinology · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Niti KumariBiomedical Sciences Department, Creighton University School of Medicine, Omaha, NE 68178, USA.
Somrudee ReabroiBiomedical Sciences Department, Creighton University School of Medicine, Omaha, NE 68178, USA.ORCID https://orcid.org/0000-0003-4816-842X
Brian J NorthBiomedical Sciences Department, Creighton University School of Medicine, Omaha, NE 68178, USA.ORCID https://orcid.org/0000-0003-0463-7028
Creighton University · US

Funding

Mechanisms Controlling BubR1 Regulation of Cancer and AgingK01AG052627 · NIA · CREIGHTON UNIVERSITY · PI NORTH, BRIAN J. · 2016 to 2020
$620k
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) represent a large family of transmembrane proteins that transduce an external stimulus into a variety of cellular responses. They play a critical role in various pathological conditions in humans, including cancer, by regulating a number of key processes involved in tumor formation and progression. The epithelial-mesenchymal transition (EMT) is a fundamental process in promoting cancer cell invasion and tumor dissemination leading to metastasis, an often intractable state of the disease. Uncontrolled proliferation and persistent metabolism of cancer cells also induce oxidative stress, hypoxia, and depletion of growth factors and nutrients. These disturbances lead to the accumulation of misfolded proteins in the endoplasmic reticulum (ER) and induce a cellular condition called ER stress (ERS) which is counteracted by activation of the unfolded protein response (UPR). Many GPCRs modulate ERS and UPR signaling via ERS sensors, IRE1

Indexed as

AnimalsEndoplasmic Reticulum StressEndoribonucleasesEpithelial-Mesenchymal TransitionHumansReceptors, G-Protein-CoupledUnfolded Protein ResponseEndoribonucleasesReceptors, G-Protein-Coupled

Identifiers

PMID33746610
PMCPMC7943314
OpenAlexW3134779736

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.